Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies (Q36613900)
Jump to navigation
Jump to search
scientific article published on February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies |
scientific article published on February 2013 |
Statements
1 reference
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies (English)
1 reference
Alessandro Tuzi
1 reference
Davide Lombardi
1 reference
Diana Crivellari
1 reference
Loredana Militello
1 reference
Tiziana Perin
1 reference
Manuela La Grassa
1 reference
Samuele Massarut
1 reference
Andrea Veronesi
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference